<![CDATA[PANXEON Liquid Biopsy Demonstrates Potential for Detecting Early Pancreatic Cancer]]>

Data ReadoutpositivePANXEON Liquid BiopsyPositive

AI Analysis

Summary

PANXEON's blood-based miRNA assay combined with CA19-9 demonstrated improved early detection of pancreatic ductal adenocarcinoma in a prospective, multicenter study. The liquid biopsy approach shows potential for earlier diagnosis of pancreatic cancer.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Blood-based miRNA assay combined with CA19-9 demonstrated improved early detection of pancreatic ductal adenocarcinoma in prospective, multicenter study

Importance:5/10

Sentiment:

0.65

liquid biopsypancreatic cancerearly detectionmiRNA assayCA19-9prospective studymulticenter

Read the original article

Published by Cancer Network on September 22, 2026 8:00 PM

Read Original